Concepedia

Publication | Open Access

Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment

192

Citations

13

References

2021

Year

Abstract

Hepatic impairment trial: ClinicalTrials.gov, NCT01790607 (https://clinicaltrials.gov/ct2/show/NCT01790607). Renal impairment trial: EudraCT Number: 2014-004575-23.

References

YearCitations

Page 1